Phase 0 Clinical Chemoprevention Trial of the AKT Inhibitor SR13668

Por Reid, Joel M., Walden, Chad, Qin, Rui, Allen Ziegler, Katie L., Haslam, John L., Rajewski, Roger A., Warndahl, Roger, Fitting, Cindy L., Boring, Daniel, Szabo, Eva, Crowell, James, Perloff, Marjorie, Jong, Ling, Mandrekar, Sumithra J., Ames, Matthew M., Limburg, Paul J.
Publicado em 2011